MedPath

Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

Not Applicable
Conditions
Multiple Sclerosis
Fatigue
Interventions
Device: Online Therapy for Fatigue
Registration Number
NCT06441617
Lead Sponsor
Accelerated Cure Project for Multiple Sclerosis
Brief Summary

CAFE-MS will assess the effectiveness of two online programs for fatigue in multiple sclerosis (MS). Although they differ, both of these online programs contain information about MS and fatigue intended to help people with MS understand and manage their fatigue.

This large-scale, decentralized clinical trial is projected to enroll 2,000 people with MS. The collaboration between iConquerMS and 5 Veterans Affairs (VA) sites in the MS Centers of Excellence is designed to ensure sufficient representation of people with MS from populations traditionally under-represented in MS clinical trials.

The study is a 3-arm, randomized controlled clinical trial with study participation lasting 1 year. Two of the trial arms will include one of two online programs for managing fatigue in MS added to the trial participants' usual MS treatment, and the third arm will include usual MS treatment alone. The online program phase of the trial lasts for 6 months after randomization followed by a final study visit at 12 months. Participants in the usual MS treatment alone arm for the first 6 months will have an opportunity to choose one of the online programs for the final 6 months of the trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Informed consent by person with MS
  • Living in the US
  • Age ≥ 22
  • Confirmed diagnosis of MS by a physician, who is a neurologist or has access to a neurologist's statement of diagnosis
  • Fatigue Severity Scale score at or above eligibility threshold
  • Fluent in English
  • Willingness to engage in self-administration of an online intervention for 24 weeks and complete follow-up assessments
  • Access to the internet and e-mail with a compatible device (smartphone, computer, or tablet)
  • No MS relapse / no steroid treatment in the 4 weeks prior to answering the screening questionnaire (self-reported)
  • No disease-modifying therapeutic (DMT) started in the 4 weeks prior to answering the screening questionnaire (self-reported)
Exclusion Criteria
  • Unwilling or unable to consent
  • Refusal to saving, processing and forwarding of pseudonymized data
  • Concurrent participation in another interventional trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fatigue Program A added to Treatment as UsualOnline Therapy for FatigueAn MS-specific fatigue management program, delivered as a stand-alone, fully automated intervention via an internet-browser.
Fatigue Program B added to Treatment as UsualOnline Therapy for FatigueFatigue Program B will use a web-based interface with similar design and functionality as Fatigue Program A.
Primary Outcome Measures
NameTimeMethod
Chalder Fatigue ScaleDay 180

The scale contains 11 items covering physical fatigue (items 1-7) and mental fatigue (items 8-11).

Secondary Outcome Measures
NameTimeMethod
PROMIS MS HealthDay 180

PROMIS MS Health has 14 domains, each comprising four 5-point Likert scale items, covering mobility limitations, spasticity, reduced hand and arm function, fatigue, pain, numbness, cognition issues, sleep disturbances, bowel and bladder dysfunction, vision problems, dizziness and vertigo, sexual dysfunction, mood and emotional changes plus a single 5-point Likert scale item for overall health.

SymptoMScreenDay 180

SymptoMScreen has twelve 7-point Likert scale items covering how each of the following MS symptoms affects everyday life activities: walking, hand function, spasticity, pain, sensory function, bladder control, fatigue, vision, dizziness, cognitive function, depression and anxiety.

Frenchay Activities IndexDay 180

The Frenchay Activities Index (FAI) is a measure of instrumental activities of daily living (IADL) for use with patients with neurological disorders. The FAI assesses a broad range of activities associated with everyday life that the patient has participated in within the recent past, broken into 3 domains: domestic chores, leisure/work, and outdoor activities.

PROMIS FatigueMS-8aDay 180

The PROMIS FatigueMS-8a questionnaire has eight 5-point Likert scale items on different aspects of fatigue.

Trial Locations

Locations (4)

Washington VA Medical Center

🇺🇸

Washington, District of Columbia, United States

Portland Va Medical Center

🇺🇸

Portland, Oregon, United States

Baltimore VA Medical Center

🇺🇸

Baltimore, Maryland, United States

iConquerMS

🇺🇸

Waltham, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath